Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease.

Aim: To investigate the capability of a biochemical and clinical model, BioCliM, in predicting the survival of cirrhotic patients.

Methods: We prospectively evaluated the survival of 172 cirrhotic patients. The model was constructed using clinical (ascites, encephalopathy and variceal bleeding) and biochemical (serum creatinine and serum total bilirubin) variables that were selected from a Cox proportional hazards model.